Two insiders at Moderna, Inc. (MRNA) have recently divested a significant number of shares. President Stephen Hoge sold a total of 80,575 shares across two transactions on September 14 and 15, 2026, realizing approximately $11.69 million.
These transactions occurred amidst broader insider selling activity at the biotechnology company. In the preceding weeks, other executives, including James M. Mock and Shannon Thyme Klinger, also sold shares, totaling an additional $5.17 million.
While insider sales can be motivated by various personal financial decisions such as diversification or tax planning, multiple sales by senior management can sometimes attract investor attention. The company's stock performance and future outlook will be closely watched following these disclosures.